Strategy for development of generic drug superstars in ChinaSU Wei-ping, SONG Rui-lin, WANG Yi-tao, SHI Lu-wen200-203
Ideas for clinically evaluating the treatment of idiopathic thrombocytopenic purpura based on the guidance principle of clinical study on new drug of traditional Chinese medicineLIU Song-shan, HAN Hu, YANG Ren-xu204-207
The past 30 years and the future of drug registration and R&D in China (2)——development of drug evaluation and its contribution to biological product R&D in ChinaCHANG Wei-hong, HAN Pei, CAO Lian-zhi208-212
Current status of research on glucokinase targeting drugs for type 2 diabetesLEI Lei, LIU Quan, SHEN Zhu-fang213-218,234
Antibacterial therapy for the infections of NDM-1 producing EnterobacteriaceaeXIAO Yong-hong219-223,229
Development in research of natural phenylethanoid glycosidesZHENG Xiao-ke, LIU Yuan-yuan, FENG Wei-sheng, WANG Yan-zhi, GUO Yong-hui230-234
Advances in non-injectable formulations of Panax notoginseng saponinLAI Ling, LIU Hua-gang, CHEN Ming, LIU Guan-ping235-238,241
Efficacy of Tanreqing injection in the treatment of 40 children with bronchiolitisYE Jin, ZHANG Yong-chun, WU Yan-ming, WANG Ming-ming239-241
Efficacy of Danhong injection in 50 patients with arteriosclerosis obliteransLI Li, DUAN Wei, LIU Xin-bin, LI Hai-na, ZHANG Hai-tao, LI Ling-ke, LIU Chao-zhong, ZHANG Hong-chao242-244